日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IL-22/IL-22R1 pathway enhances cholangiocarcinoma progression via ERK1/2 activation.

IL-22/IL-22R1通路通过ERK1/2激活促进胆管癌进展

Zhou Jin, Chen Jing-Rui, Li Jin-Ming, Han Shuang-Qing, Deng Xi-Yue, Li Zhong-Min, Tong Wen, Wang Chao, Bai Yi, Zhang Ya-Min